Announcement

Collapse
No announcement yet.

Cell: Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Cell: Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy

    Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy

    Taia T. Wang7
    , Jad Maamary7
    , Gene S. Tan
    , Stylianos Bournazos
    , Carl W. Davis
    , Florian Krammer
    , Sarah J. Schlesinger
    , Peter Palese
    , Rafi Ahmed
    , Jeffrey V. Ravetch
    7Co-first author


    DOI: http://dx.doi.org/10.1016/j.cell.2015.06.026 |


    Highlights

    • ?Dynamic changes in Fc glycan composition following influenza vaccination
    • ?Sialylated Fc glycan abundance on anti-HA IgG predicts vaccine response
    • ?Sialylated Fc immune complexes engage CD23 and BCR to modulate affinity maturation
    • ?IgGs elicited by sialylated Fc immune complexes protect broadly against H1 viruses



    Summary

    Protective vaccines elicit high-affinity, neutralizing antibodies by selection of somatically hypermutated B cell antigen receptors (BCR) on immune complexes (ICs). This implicates Fc-Fc receptor (FcR) interactions in affinity maturation, which, in turn, are determined by IgG subclass and Fc glycan composition within ICs. Trivalent influenza virus vaccination elicited regulation of anti-hemagglutinin (HA) IgG subclass and Fc glycans, with abundance of sialylated Fc glycans (sFc) predicting quality of vaccine response. We show that sFcs drive BCR affinity selection by binding the Type-II FcR CD23, thus upregulating the inhibitory FcγRIIB on activated B cells. This elevates the threshold requirement for BCR signaling, resulting in B cell selection for higher affinity BCR. Immunization with sFc HA ICs elicited protective, high-affinity IgGs against the conserved stalk of the HA. These results reveal a novel, endogenous pathway for affinity maturation that can be exploited for eliciting high-affinity, broadly neutralizing antibodies through immunization with sialylated immune complexes.



Working...
X